Non-small Cell Lung Cancer With Central Nervous System Metastasis

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 13, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Lung Cancer With Central Nervous System Metastasis
Interventions
OTHER

lung cancer with brain /leptomeningeal metastasis

Cerebrospinal fluid was obtained from the cerebrospinal cavity of non-small cell lung cancer patients with central nervous system metastasis, blood was obtained from veins, and metastatic lung cancer tumor tissue was obtained from surgically resected brain tumors or meningeal tumors. Then comprehensively analyze the exosomes contained in the aforementioned samples, and compare and analyze the clinical data of the patients, so as to explore whether the cancer cell-related substances contained in the cerebrospinal fluid, blood and tumor tissue can be used to predict lung cancer metastasis and Bioindicators of treatment effect.

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER